Anebulo Pharmaceuticals, Inc. (ANEB:OTC) closed at $0.295 on October 20, 2026, up 29,400.00% on the day. The stock trades 89.4% below its 52-week high of $2.77 and 29,400.0% above its 52-week low of $0.001. Anebulo Pharmaceuticals, Inc. is part of the Health Care sector.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company. It is developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.
Find more stocks like ANEB with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.